newsfilter
← Latest News
Business Wire·

Agenus to Provide Third Quarter 2026 Financial Report and Development Update

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Company will release its third quarter 2026 financial results before the market opens on Thursday,